Bessemer Securities LLC Merck & Co., Inc. Transaction History

Bessemer Securities LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $648,585 - $720,279	-6,300 Reduced 56.95%	4,763 $490,000
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $103,179 - $112,461	-950 Reduced 7.91%	11,063 $1.28 Million
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $39,348 - $50,449	450 Added 3.89%	12,013 $1.33 Million
Q2 2022 Aug 10, 2022	BUY	$83.49 - $94.64 $400,752 - $454,272	4,800 Added 70.97%	11,563 $1.05 Million
Q4 2021 Jan 31, 2022	SELL	$72.28 - $90.54 $49,656 - $62,200	-687 Reduced 9.22%	6,763 $518,000
Q2 2021 Aug 10, 2021	BUY	$70.31 - $77.77 $77,341 - $85,547	1,100 Added 17.32%	7,450 $579,000
Q2 2020 Aug 12, 2020	SELL	$70.42 - $80.13 $373,578 - $425,089	-5,305 Reduced 45.52%	6,350 $491,000
Q1 2020 Apr 30, 2020	BUY	$63.36 - $87.82 $110,880 - $153,685	1,750 Added 17.67%	11,655 $897,000
Q4 2019 Feb 04, 2020	BUY	$77.58 - $87.54 $411,561 - $464,399	5,305 Added 115.33%	9,905 $901,000
Q4 2018 May 21, 2019	BUY	$65.24 - $75.71 $300,104 - $348,266	4,600 New	4,600 $351,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Bessemer Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Bessemer Securities LLC with notifications on news.